<DOC>
	<DOCNO>NCT00563017</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , tolerability safety patient long-acting Risperidone microshpheres injection . The major advantage long-acting injection oral medication facilitation compliance medication take . Non-compliance common among schizophrenic frequent cause relapse .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Long-acting Risperidone Microspheres Patients With Schizophrenia Other Psychotic Disorders When Switching From Typical Antipsychotic ( Oral/Depot ) Atypical Oral Other Than Risperidone</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Catatonia</mesh_term>
	<mesh_term>Schizophrenia , Disorganized</mesh_term>
	<mesh_term>Schizophrenia , Paranoid</mesh_term>
	<mesh_term>Schizophrenia , Catatonic</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Subjects schizophrenia another psychotic disorder accord DSM IV criterion require long term antipsychotic therapy Currently treat either atypical antipsychotic , risperidone , conventional depot antipsychotic oral conventional antipsychotic Subject symptomatically stable stable dose antipsychotic last month Subject and/or patient 's relative , guardian legal representative sign informed consent form First antipsychotic treatment ever On clozapine last 3 month Serious unstable medical condition History current symptom tardive dyskinesia History neuroleptic malignant syndrome Pregnant breastfeed female Female patient childbearing potential without adequate contraception . Participation investigational drug trial 30 day prior selection Known intolerance/nonresponder risperidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Catatonic Schizophrenia</keyword>
	<keyword>Disorganized Schizophrenia</keyword>
	<keyword>Paranoid Schizophrenia</keyword>
	<keyword>Undifferentiated Schizophrenia</keyword>
	<keyword>Schizo-affective disorder</keyword>
</DOC>